Global Aminoglycosides Antibiotics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.Aminoglycosides are potent bactericidal antibiotics that act by creating fissures in the outer membrane of the bacterial cell. They are particularly active against aerobic, gram-negative bacteria and act synergistically against certain gram-positive organisms.
According to our (Global Info Research) latest study, the global Aminoglycosides Antibiotics market size was valued at US$ 780 million in 2023 and is forecast to a readjusted size of USD 703 million by 2030 with a CAGR of -1.2% during review period.
The key players of Aminoglycosides Antibiotics include Jemicare, Teva, Novartis and Fangyuan-pharma. The top four manufacturers hold approximately 15% of the global market share,.
In terms of product type, Tobramycin is the largest segment, with a share of 34%. And in terms of application, Hospital has a share about 38 percent.
This report is a detailed and comprehensive analysis for global Aminoglycosides Antibiotics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Aminoglycosides Antibiotics market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
Global Aminoglycosides Antibiotics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
Global Aminoglycosides Antibiotics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
Global Aminoglycosides Antibiotics market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Aminoglycosides Antibiotics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Aminoglycosides Antibiotics market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jemicare, Teva, Novartis, Fangyuan-pharma, Aike Pharmaceutical, Cipla, Pfizer, Fresenius Kabi, Sun Pharma, Hikma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Aminoglycosides Antibiotics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tobramycin
Gentamicin
Amikacin
Etimicin
Others
Market segment by Application
Hospital
Clinic
Others
Major players covered
Jemicare
Teva
Novartis
Fangyuan-pharma
Aike Pharmaceutical
Cipla
Pfizer
Fresenius Kabi
Sun Pharma
Hikma
Lannett Company
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Aminoglycosides Antibiotics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Aminoglycosides Antibiotics, with price, sales quantity, revenue, and global market share of Aminoglycosides Antibiotics from 2019 to 2024.
Chapter 3, the Aminoglycosides Antibiotics competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Aminoglycosides Antibiotics breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Aminoglycosides Antibiotics market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Aminoglycosides Antibiotics.
Chapter 14 and 15, to describe Aminoglycosides Antibiotics sales channel, distributors, customers, research findings and conclusion.